Clinical Trials Logo

Filter by:
NCT ID: NCT00786097 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - Compatibility

Start date: July 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDETINLYN Tangerine Mix.None.

NCT ID: NCT00785850 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.

Start date: August 2008
Phase: Phase 3
Study type: Interventional

To prove the safety in normal conditions of use.

NCT ID: NCT00785837 Recruiting - Perinatal Care Clinical Trials

Effects of Hydrotherapy in Pain and Quality of Sleep's Cycles in Preterm Newborn on Neonatal Intensive Care Units

hydrotherapy
Start date: July 2005
Phase: N/A
Study type: Interventional

Researchers suggest that the protection of the cycles of sleep is essential for neurodevelopment, learning, memory and preservation of brain plasticity to the individual's life. Recent research shows that technical bath promote reduction of crying, anxiety and improves the behavior of newborns.

NCT ID: NCT00785811 Terminated - Muscular Fatigue Clinical Trials

Effect of Chronic Supplementation of L-arginine in the Muscular Performance

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The primary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular fatigue of the quadriceps, expressed in terms of the Fatigue Resistance Factor (FRF). The secondary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular force the quadriceps.

NCT ID: NCT00785785 Completed - Clinical trials for Gastrointestinal Stromal Tumor (GIST)

A Study of Nilotinib Versus Imatinib in GIST Patients

ENESTg1
Start date: March 2009
Phase: Phase 3
Study type: Interventional

This study will evaluate efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).

NCT ID: NCT00785720 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo Avaluation

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINBACK Sweet Flower.

NCT ID: NCT00785681 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility

Start date: July 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINBACK Sweet Flower.

NCT ID: NCT00785655 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility

Start date: July 2008
Phase: Phase 3
Study type: Interventional

To demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINLYN Sweet Flower.

NCT ID: NCT00785642 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.

Start date: August 2008
Phase: Phase 3
Study type: Interventional

To prove the safety of the gynaecological formulation in normal conditions of use.

NCT ID: NCT00785590 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.

Start date: August 2008
Phase: Phase 3
Study type: Interventional

To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINLYN Sweet Flower.